In angioplasty, the catheter with the balloon is passed through the artery to the blockage, and then inflated to increases of the blood flow to the heart and widen the opening. Various materials are used to make these balloons which include nylon, pebax, polyurethane, and others. Different types of balloons are available in the medical industry such as normal balloon catheter, drug-eluting balloon cutting balloon, and others. In a drug-eluting balloon, the anti-proliferative drug is provided through a balloon when the balloon inflated this drug is released. All of them are used in angioplasty in order to treat heart diseases or cardiovascular diseases. Their use reduces complications after a heart attack in addition to this, the use of balloons in angioplasty has replaced the bypass surgery. Deaths caused due to heart diseases are growing amongst the new generation, according to the World Health Organisation, most of the deaths in the world are caused due to cardiovascular diseases. Taking around 17.9 million lives every year which is an estimated 31.00% of all deaths worldwide. Growing population and healthcare awareness is expected to increase the demand of the market. Angioplasty Balloon Market accounted 2.6 USD billion in 2020 and is expected to reach 3.6 USD billion by 2030 growing with a CAGR of 3.4% during the forecast period.

Market Segmentation:

On the basis of product type, the angioplasty balloon market is segmented into normal balloon catheters, drug-eluting balloons, cutting balloons, and others. On the basis of application, the market is segmented into peripheral and coronary. On the basis of the end user, the market is segmented into hospitals, ambulatory surgery centers, and cath labs. On the basis of region, the angioplasty balloon market is segmented into North America, Europe, Asia Pacific, and RoW.

Market Dynamics and Factors:

The necessity of the balloons for the medical procedure of angioplasty and growing victims of cardiovascular diseases worldwide are the major driving factors of the angioplasty balloon market. In addition to this development of advanced materials for making balloons such as the use of different polymers. Resulting in reduced cost which will further boost the angioplasty balloon market in the upcoming years. Growing population in emerging countries like India, China fuels the healthcare or medical industry which leads to an increase in demand for the healthcare equipment. An unhealthy lifestyle of the populace in the developed countries also helps in the growth of the angioplasty balloon market. However, price clash and an increase in key players is hindering the angioplasty balloon market growth. Research development in advanced materials and angioplasty will further create new opportunities in upcoming years.

Geographic Analysis:

North America has dominated the angioplasty balloon market and expected to continue its supremacy during the forecast period. With the growing development of advanced materials and angioplasty, an increase in cardiovascular patients owing to an unhealthy lifestyle, and the presence of top manufacturers such as Cardinal Health, Cook Medical. Asia Pacific is also expected to witness rapid growth due to the rising population and growing health awareness amongst the populace, and growing healthcare sector. Europe is expected to grow at a steady pace with the growing healthcare sector.

Competitive Scenario:

Some of the key players in the angioplasty balloon industry are Abbott Laboratories, Boston Scientific Corp., Cook Medical, Inc., Cardinal Health (Cordis), Becton Dickinson and Company (C.R. Bard), ENDOCOR GmbH, and Johnson & Johnson, Medtronic PLC, Spectranetics Corp.

Angioplasty Balloon Market Report Scope